Immune Development in Early Life (IDEaL) (U01 Clinical Trial Not Allowed)
Funding Opportunity RFA-AI-20-077 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement is to support research to define the mechanisms regulating the establishment, development and maintenance of immunity throughout childhood (from birth to less than 18 years of age), including the impact of pathogenic or non-pathogenic microbes or vaccination against infectious diseases, allergens or environmental pollutants on immune ontogeny and function. This program will establish collaborations among immunologists, neonatologists, pediatricians, systems biologists, and microbiologists t...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 12, 2021 Category: Research Source Type: funding
Notice of Participation of NIMH in PAR-20-300, "Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R01 Clinical Trial Optional)"
Notice NOT-MH-21-130 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 30, 2020 Category: Research Source Type: funding
P4 Challenge: Innovations in Pediatric Primary Care to Improve Child Health
Challenge competition seeking innovative approaches to increase access to and utilization of well-child visits and/or immunizations services within primary care settings. Geographic coverage: Nationwide -- Health Resources and Services Administration, Maternal and Child Health Bureau, U.S. Department of Health and Human Services (Source: Funding opportunities via the Rural Health Information Hub)
Source: Funding opportunities via the Rural Health Information Hub - December 18, 2020 Category: American Health Source Type: funding
Pre-Application Webinar for RFA-ES-20-007, Pediatric and Reproductive Environmental Health Scholars program (K12 Independent Clinical Trial Not Allowed)
Notice NOT-ES-21-001 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 27, 2020 Category: Research Source Type: funding
Discovery of the Genetic Basis of Childhood Cancers and of Structural Birth Defects: Gabriella Miller Kids First Pediatric Research Program (X01 Clinical Trial Not Allowed)
Funding Opportunity PAR-21-040 from the NIH Guide for Grants and Contracts. As part of the Gabriella Miller Kids First Pediatric Research Program (Kids First), the NIH invites applications to submit samples from pediatric cohorts for whole genome sequencing at a Kids First-supported sequencing center. Applicants are encouraged to propose sequencing of existing pediatric cancer cohorts to elucidate the genetic contribution to childhood cancers, or to expand the range of disorders included within the Kids First Data Resource to investigate the genetic etiology of structural birth defects. Whole genome, exome, and transcri...
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 27, 2020 Category: Research Source Type: funding
Supporting Providers and Families to Access Telehealth and Distant Care Services for Pediatric Care: Rural Practices Telehealth Stipend
Technical assistance, stipends, and a virtual learning community for community-based practices that serve pediatric patients in rural areas. Assistance will support the implementation of telehealth and distance care. Geographic coverage: Nationwide -- American Academy of Pediatrics, Maternal and Child Health Bureau, National Rural Health Association (Source: Funding opportunities via the Rural Health Information Hub)
Source: Funding opportunities via the Rural Health Information Hub - October 7, 2020 Category: American Health Source Type: funding
Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research (R21 Clinical Trial Not Allowed)
Funding Opportunity RFA-HD-21-030 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to address the needs of the maternal and pediatric HIV scientific community for research data translation and sharing. This initiative will support secondary data analyses using archived HIV/AIDS data and specimens to generate new research questions and findings relevant to the scientific mission and priorities of the NICHD, Maternal and Pediatric Infectious Disease Branch (MPIDB), and Office of AIDS Research (OAR). The goal of this initiative is to encourage the scientific communi...
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 1, 2020 Category: Research Source Type: funding
Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2021, 2022, and 2023 (P50 Clinical Trial Required)
Funding Opportunity PAR-20-305 from the NIH Guide for Grants and Contracts. Through this funding opportunity announcement (FOA), the National Cancer Institute (NCI) invites applications for P50 Research Center Grants for Specialized Programs of Research Excellence (SPORE). The program will fund P50 SPORE grants to support state-of-the-art investigator-initiated translational research that will contribute to improved prevention, early detection, diagnosis, and treatment of an organ-specific cancer or a highly related group of cancers. For the purpose of this FOA, a group of highly related cancers are those that are deriv...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 28, 2020 Category: Research Source Type: funding
Request for Information (RFI): Pediatric preclinical models (cell lines and patient-derived xenografts) for which genomic characterization will enhance research value
Notice NOT-CA-20-108 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 25, 2020 Category: Research Source Type: funding
Pediatric and Reproductive Environmental Health Scholars (PREHS): Strengthening the Pipeline (K12 Clinical Trial Not Allowed)
Funding Opportunity RFA-ES-20-007 from the NIH Guide for Grants and Contracts. The goal of the Pediatric and Reproductive Environmental Health Scholars (PREHS) program is to create of a strong network of healthcare professionals who possess the skills and knowledge to address the complexities of pediatric and reproductive environmental health. The PREHS program is envisioned as a strategy to bridge clinical training with a career in environmental health research relevant to pediatrics and reproductive health. As such, the PREHS program will provide training in clinical practice in environmental health, community-level a...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 22, 2020 Category: Research Source Type: funding
Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R01 Clinical Trial Optional)
Funding Opportunity PAR-20-300 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to encourage applications that will perform basic, translational and clinical research to (1) advance the understanding of underlying mechanisms of drug action; (2) discover and develop novel therapeutics; (3) enhance the usage of existing drugs or drug repurposing for safer and more effective treatment for pregnant women, lactating women, neonates and children. The overall goal is to improve drug safety and efficacy for maternal and pediatric ?precision therapeutics. (Source: NIH Fun...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 11, 2020 Category: Research Source Type: funding
Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional)
Funding Opportunity PAR-20-299 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to encourage applications that will perform basic, translational and clinical research to (1) advance the understanding of underlying mechanisms of drug action; (2) discover and develop novel therapeutics; (3) enhance the usage of existing drugs or drug repurposing for safer and more effective treatment for pregnant women, lactating women, neonates and children. The overall goal is to improve drug safety and efficacy for maternal and pediatric precision therapeutics. (Source: NIH Fund...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 11, 2020 Category: Research Source Type: funding
Pre-Application Webinar for NCI Pediatric In Vivo Testing Program and NCI Pediatric In Vivo Testing Program Coordinating Center (RFA-CA-20-034, RFA-CA-20-041)
Notice NOT-CA-20-096 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 31, 2020 Category: Research Source Type: funding
NCI Pediatric In Vivo Testing Program Coordinating Center (U24 Clinical Trial Not Allowed)
Funding Opportunity RFA-CA-20-041 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is for a Coordinating Center for the NCI Pediatric in Vivo Testing Program (henceforth termed the Ped-In Vivo-TP). The main goal for the Ped-InVivo-TP is to use genomically-characterized pediatric cancer models to develop a rigorous preclinical testing system to generate reliable data that can be used to inform new agent prioritization decisions for childhood cancers. The Ped-In Vivo-TP has two parts: a) research teams for in vivo testing to determine the activity of pediatric anticancer drug candi...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 25, 2020 Category: Research Source Type: funding
NCI Pediatric In Vivo Testing Program (U01 Clinical Trial Not Allowed)
Funding Opportunity RFA-CA-20-034 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is for Research Teams to form the NCI Pediatric in Vivo Testing Program (henceforth termed the Ped-InVivo-TP). The Research Teams of the Ped-InVivo-TP will determine the activity of pediatric anticancer drug candidates using preclinical models relevant to the cancer(s) on which their team focuses (supported under this FOA) and will work in concert with the Ped-InVivo-TP Coordinating Center (supported under RFA-CA-20-041). The Research Teams will use genomically characterized pediatric cancer models ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 25, 2020 Category: Research Source Type: funding
